Vanguard Fiduciary Trust
PDSB icon

Vanguard Fiduciary Trust’s PDS Biotechnology PDSB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
357,144
+49,833
+16% +$52.9K ﹤0.01% 3435
2026
Q1 		$186K Buy
+307,311
New +$231K ﹤0.01% 3540

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust's PDSB Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its PDS Biotechnology (PDSB) stake by 16% in Q2 2026, buying an estimated $52.9K and bringing the position to 357,144 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #3435.

Vanguard Fiduciary Trust first reported a position in PDSB in Q1 2026 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Vanguard Fiduciary Trust held 357,144 shares of PDS Biotechnology worth $315K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 49,833 PDS Biotechnology shares in Q2 2026, an estimated $52.9K.
  • PDS Biotechnology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3435 holding.
  • Vanguard Fiduciary Trust first reported a position in PDS Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 51 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.